Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Post by cool888on Jul 24, 2021 12:14pm
182 Views
Post# 33600873

$RVV - Interesting Read !

$RVV - Interesting Read !From Biomedical_Trader on Reddit:

Our Korean manufacturer passed the company to his son

Our supplier of bucillamine, Kyungdong Pharmaceutical Co. (KOSDAQ: 011040), has a new CEO. I recommend using a translation-capable browser since the article is in Korean.

[https://www.newsway.co.kr/news/view?ud=2021070118225478945](https://www.newsway.co.kr/news/view?ud=2021070118225478945)

For context, a lot of businesses in South Korea are a family-run dynasty called a "chaebol". The prominence of these dynastic arrangements has been declining recently with the most famous chaebol, Samsung, stating that there would be no succession. This has been largely attributed to South Korea's increasing regulatory scrutiny of chaebols and the 50% inheritance tax.

[https://www.koreaherald.com/view.php?ud=20200618000319](https://www.koreaherald.com/view.php?ud=20200618000319)

Given the current state of affairs, Deok-Hee Ryu's decision to hand over the company to his son, Ki-Seong Ryu reflects expectations that materially significant events could occur in the near future. Handing over the company prior to an expected breakthrough is the simplest way to preserve control and capital in the family, as it would cost significantly more capital to transfer the company after the fact.

https://www.koreaherald.com/view.php?ud=20200618000319
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities